Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Wageningen Team on AgBio Tests

NEW YORK (GenomeWeb News) – Luminex today announced that it has licensed its xMAP technology and the Luminex Bioscience Group’s assay development capabilities to Wageningen University and Research Center in the Netherlands.
 
Wageningen will use the xMAP multiplex technology for a variety of agricultural biotech areas including plant pathogen detection, epidemiology, food safety, and marker-assisted plant and animal breeding programs. Financial terms of the agreement were not disclosed.
 
Though Luminex has focused most of its efforts on developing assays — or partnering with other firms that develop assays — for human health, pharmaceutical, or biomedical research applications, the alliance with Wageningen follows Luminex’s partnership in the food safety field with Tyson Foods, which was signed in January.
 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.